31.07.2015 • News

Bayer CEO said Syngenta “not a Logical Fit”

Marijn Dekkers, CEO, Bayer
Marijn Dekkers, CEO, Bayer

Swiss agrochemicals group Syngenta, currently being pursued by US giant Monsanto, is” not a logical acquisition target for Bayer,” Marijn Dekkers, CEO of the German group, said in an interview with the business news channel CNBC.

Both Syngenta and Bayer are very strong in chemical crop protection, Dekkers pointed out – in contrast to Monsanto, which is seeking to reduce its dependence on GMO seeds.

Up to now, Dekkers has been loath to comment on the international showdown; however, Liam Condon, CEO of Bayer CropScience, told the news agency Bloomberg in June that if the Monsanto bid is eventually accepted by Syngenta shareholders, other of the industry’s players could be forced to review their strategies.

Condon explained that many players have cooperation agreements with either Monsanto or Syngenta, or both, as well as with each other. Any change in ownership structure could change the rules of the deals.

Both Bayer and German rival BASF in the past have been named as candidates to buy Syngenta's seed business, which Monsanto would probably have to sell to allay antitrust concerns.

 

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.